One industry’s waste is another’s treasure.
Genomics is enabling biological processes to support the circular economy—from taking plastic waste out of the environment through enzymes and bacteria that can break the plastics down into reusable chemicals and components, to turning paper and pulp industry waste into high value products. The Canadian Genomics Enterprise’s investments in paper and pulp waste are impacting the industry already, with significant commitments to uptake.
The circular bioeconomy is a USD $7.7 trillion global opportunity. In Canada, the accelerated adoption of the circular bioeconomy is integral to a net-zero economy future with a projected $240 billion market in Canada by 2031. With the federal government committed to supporting the circular economy, including its biological components, genomics can continue to valorize by-products of production.
With collaboration across the Canadian Genomics Enterprise